Skip to main content

Kendall Capital Management

Position in GILD — Gilead Sciences, Inc.

CIK 1731372 ROCKVILLE, MD

Position in GILD

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$1,056,455
-$137,527 QoQ
Shares Held
8,362
-2.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#1,045
of 2,266 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Kendall Capital Management holds $22,925,368 across 11 Drug Manufacturers - General names. GILD ranks #8 (4.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 GILD
Gilead Sciences, Inc.
This page
8,362 $1,056,455

All Filings in GILD

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,056,455 8,362
2026-03-31 $1,193,982 8,567
2025-12-31 $1,061,946 8,652
2025-09-30 $989,232 8,912
2025-06-30 $978,095 8,822
2025-03-31 $976,739 8,717
2024-12-31 $802,880 8,692
2024-09-30 $702,746 8,382
2024-06-30 $502,019 7,317
2024-03-31 $264,579 3,612
2023-12-31 $290,582 3,587
2023-09-30 $268,809 3,587
2023-06-30 $207,472 2,692
2021-03-31 $201,968 3,125
2020-12-31 $206,823 3,550
2020-09-30 $235,382 3,725
2020-06-30 $300,066 3,900
2020-03-31 $292,685 3,915